Aerie Pharmaceuticals: Guidance Is Unachievable After Failed Drug Launches; 70%+ Downside
by SA PRO Short Ideas
Contributor since 2019 / 1015 Followers
Contributor since 2019 / 1015 Followers
5 years ago
Summary: Sell-side estimates for this quarter’s revenue are too high and have begun to be